Categories: Analysts

Q3 focus will be on Cineplex’s media segment, says Canaccord Genuity


With box office sales experiencing slow but steady growth investors should focus on Cineplex’s media business, which has been recovering, says Canaccord Genuity analyst Aravinda Galappatthige.

Recently released data from the Motion Picture Theatre Associate of Canada revealed that Canadian box office sales were up 2% in Q3, 2013. This means there will be little room for mystery on the box office side of Cineplex’s (TSX:CGX) upcoming Q3 results, and investors should focus on the company’s media segment, says Canaccord Genuity analyst Aravinda Galappatthige.

On Tuesday, November 5th, Cineplex will post its third quarter results. The company is following on a Q2 in which it delivered EBITDA of $58.7 million on revenue of at $301.6 million, handily beating the street consensus of $290.9 million.

Galappatthige notes that Cineplex’s media business has experienced a rebound in recent quarters, and he expects further strength in the upcoming quarter. The company makes money from showing ads before movies, but has recently expanded its offerings in the digital signage business.

In July, Cineplex acquired EK3, a London, Ontario company with international interests and clients such as McDonalds, Walmart and Target. The move is meant to complement Cineplex’s own burgeoning digital signage business. The Canaccord Genuity analyst says he is bullish on the company’s ability to drive new revenues to its media segment, particularly after its planned HD lobby screens are introduced.

That pickup of EK3 followed on the heels of Cineplex’s $200-million acquisition of 26 theatres from Empire Company Ltd. The deal, which included 24 properties in Atlantic Canada and two in Ontario, gave Cineplex a 78% shares of the Canadian movie theatre business.

In a research update to clients recently, Galappatthige maintained his HOLD rating on Cineplex, but raised his one year target price by a dollar, to $36.

Shares of Cineplex closed today up 2.5% to $41.44.

________________________

Tagged with: cgx
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you sell your OpenText stock?

OpenText (OpenText Stock Quote, Chart, News, Analysts, Financials NASDAQ:OTEX) reported fiscal second-quarter results on Feb. 5 that RBC Capital Markets… [Read More]

11 hours ago

Lightspeed is a wait-and-see stock, ATB says

ATB Capital Markets analyst Martin Toner maintained a “Sector Perform” rating on Lightspeed Commerce (Lightspeed Commerce Stock Quote, Chart, News,… [Read More]

15 hours ago

Analyst loves this data center stock

Roth Capital Markets analyst Darren Aftahi reiterated a “Buy” rating and US$94.00 12-month price target on IREN Limited (IREN Limited… [Read More]

17 hours ago

Should you sell your Snap stock?

Roth Capital Markets analyst Rohit Kulkarni reiterated a “Neutral” rating on Snap (Snap Stock Quote, Chart, News, Analysts, Financials NYSE:SNAP)… [Read More]

17 hours ago

Algonquin Power. Buy, Sell or Hold?

Desjardins Securities analyst Brent Stadler expects “another vanilla quarter” from Algonquin Power (Algonquin Power  Stock Quote, Chart, News, Analysts, Financials… [Read More]

17 hours ago

This Canadian cannabis stock is a buy, analyst says

Research Capital analyst Andre Greg McLeish reiterated a “Buy” rating and $3.50 price target on Cannara Biotech (Cannara Stock Quote,… [Read More]

17 hours ago